These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20501665)

  • 1. New targets of urocortin-mediated cardioprotection.
    Barry SP; Lawrence KM; McCormick J; Soond SM; Hubank M; Eaton S; Sivarajah A; Scarabelli TM; Knight RA; Thiemermann C; Latchman DS; Townsend PA; Stephanou A
    J Mol Endocrinol; 2010 Aug; 45(2):69-85. PubMed ID: 20501665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection.
    Gao XF; Zhou Y; Wang DY; Lew KS; Richards AM; Wang P
    Mol Cell Biochem; 2015 Jan; 398(1-2):135-46. PubMed ID: 25245818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
    Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
    Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-125a, miR-139 and miR-324 contribute to Urocortin protection against myocardial ischemia-reperfusion injury.
    Díaz I; Calderón-Sánchez E; Toro RD; Ávila-Médina J; de Rojas-de Pedro ES; Domínguez-Rodríguez A; Rosado JA; Hmadcha A; Ordóñez A; Smani T
    Sci Rep; 2017 Aug; 7(1):8898. PubMed ID: 28827743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urocortin-1 Mediated Cardioprotection Involves XIAP and CD40-Ligand Recovery: Role of EPAC2 and ERK1/2.
    Calderón-Sánchez E; Díaz I; Ordóñez A; Smani T
    PLoS One; 2016; 11(2):e0147375. PubMed ID: 26840743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes.
    Chanalaris A; Lawrence KM; Stephanou A; Knight RD; Hsu SY; Hsueh AJ; Latchman DS
    J Mol Cell Cardiol; 2003 Oct; 35(10):1295-305. PubMed ID: 14519439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo protective effects of urocortin on ischemia-reperfusion injury in rat heart via free radical mechanisms.
    Liu CN; Yang C; Liu XY; Li S
    Can J Physiol Pharmacol; 2005 Jun; 83(6):459-65. PubMed ID: 16049545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin releasing hormone and Urocortin 2 activate inflammatory pathways in cultured trophoblast cell lines.
    Novembri R; De Clemente C; Funghi L; Torricelli M; Voltolini C; Challis JR; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():200-205. PubMed ID: 26588439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Src protein tyrosine kinase plays an essential role in urocortin-mediated cardioprotection.
    Yuan Z; McCauley R; Chen-Scarabelli C; Abounit K; Stephanou A; Barry SP; Knight R; Saravolatz SF; Saravolatz LD; Ulgen BO; Scarabelli GM; Faggian G; Mazzucco A; Saravolatz L; Scarabelli TM
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):1-7. PubMed ID: 20416357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
    Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
    Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection of 17β-estradiol against hypoxia/reoxygenation in cardiomyocytes is partly through up-regulation of CRH receptor type 2.
    Cong B; Xu Y; Sheng H; Zhu X; Wang L; Zhao W; Tang Z; Lu J; Ni X
    Mol Cell Endocrinol; 2014 Jan; 382(1):17-25. PubMed ID: 24035863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death.
    Brar BK; Stephanou A; Knight R; Latchman DS
    J Mol Cell Cardiol; 2002 Apr; 34(4):483-92. PubMed ID: 11991736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kappaB activation.
    Huang M; Kempuraj D; Papadopoulou N; Kourelis T; Donelan J; Manola A; Theoharides TC
    J Mol Endocrinol; 2009 May; 42(5):397-405. PubMed ID: 19211730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SGK1 is involved in cardioprotection of urocortin-1 against hypoxia/reoxygenation in cardiomyocytes.
    Cong B; Wang L; Zhu X; Li X; Liu B; Ni X
    Can J Cardiol; 2014 Jun; 30(6):687-95. PubMed ID: 24882544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection mediated by urocortin is dependent on PKCepsilon activation.
    Lawrence KM; Kabir AM; Bellahcene M; Davidson S; Cao XB; McCormick J; Mesquita RA; Carroll CJ; Chanalaris A; Townsend PA; Hubank M; Stephanou A; Knight RA; Marber MS; Latchman DS
    FASEB J; 2005 May; 19(7):831-3. PubMed ID: 15764590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics and pharmacodynamics of urocortins 1, 2 and 3 in healthy sheep.
    Patel K; Rademaker MT; Kirkpatrick CM; Charles CJ; Fisher S; Yandle TG; Richards AM
    Br J Pharmacol; 2012 Jul; 166(6):1916-25. PubMed ID: 22339174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action and clinical implications of cardiac urocortin: a journey from the heart to the systemic circulation, with a stopover in the mitochondria.
    Kuizon E; Pearce EG; Bailey SG; Chen-Scarabelli C; Yuan Z; Abounit K; McCauley RB; Saravolatz L; Faggian G; Mazzucco A; Townsend PA; Scarabelli TM
    Int J Cardiol; 2009 Nov; 137(3):189-94. PubMed ID: 19406492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Potential Therapeutic miRNA Targets in Cardiac Ischemia-Reperfusion Injury.
    Zhou Y; Chen Q; Lew KS; Richards AM; Wang P
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):296-309. PubMed ID: 26396139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium-insensitive phospholipase A2 gene expression.
    Lawrence KM; Scarabelli TM; Turtle L; Chanalaris A; Townsend PA; Carroll CJ; Hubank M; Stephanou A; Knight RA; Latchman DS
    FASEB J; 2003 Dec; 17(15):2313-5. PubMed ID: 14563694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes.
    Smani T; Calderón-Sanchez E; Gómez-Hurtado N; Fernández-Velasco M; Cachofeiro V; Lahera V; Ordoñez A; Delgado C
    Cardiovasc Res; 2010 Aug; 87(3):459-66. PubMed ID: 20189952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.